ClinicalTrials.Veeva

Menu

Free Samples for Health (FreSH)

Hennepin Healthcare logo

Hennepin Healthcare

Status and phase

Invitation-only
Phase 2

Conditions

Cigarette Smoking

Treatments

Behavioral: Ask-Advise-Refer
Drug: Nicotine lozenge
Drug: Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05627596
UH3DE029973

Details and patient eligibility

About

The Free Samples for Health (FreSH) study tests whether providing free samples of stop smoking medicine called nicotine replacement therapy at dental visits results in a greater number of people quitting smoking than providing a gift of equal value (an electric toothbrush).

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥ 18 years old
  • smokes at least 1 combustible cigarette per day on at least 25 days of the month

Exclusion criteria

  • does not own a smartphone with internet access
  • myocardial infarction or stroke in the past 3 months
  • pregnant or breastfeeding
  • use of tobacco cessation medication in the past week

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

1,200 participants in 2 patient groups

Electric Toothbrush
Active Comparator group
Description:
Participants will receive the Ask-Advise-Refer intervention which includes an oral health practitioner asking about their tobacco use, advising them to quit smoking, and referring them to the state quitline. They will also receive a sample bag including information about smoking and oral health, the state quitline, and an electric toothbrush.
Treatment:
Behavioral: Ask-Advise-Refer
Nicotine Replacement Therapy
Experimental group
Description:
Participants will receive the Ask-Advise-Refer intervention which includes an oral health practitioner asking about their tobacco use, advising them to quit smoking, and referring them to the state quitline. They will also receive a sample bag including information about smoking and oral health, the state quitline, and a two week supply of 14mg nicotine patches and 4mg lozenges.
Treatment:
Drug: Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release
Drug: Nicotine lozenge
Behavioral: Ask-Advise-Refer

Trial contacts and locations

2

Loading...

Central trial contact

Sandra Japuntich, Ph.D.; Melissa Adkins-Hempel, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems